Truist Securities upgraded Pacira Pharmaceuticals (NASDAQ:PCRX) stock rating from Hold to Buy, significantly raising the price target to $25.00 from the previous $8.00. The stock, currently trading at ...

Truist Securities revised its position on Cargo Therapeutics (NASDAQ:CRGX), currently trading at $13.19 with a market ...

This was the stock's second consecutive day of gains.

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...

Net interest margin, which measures lending profitability, expanded to 3.07%, compared with 2.95% a year earlier. Truist's ...

Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.

Analysts at Truist Financial assumed coverage on shares of Tronox (NYSE:TROX – Get Free Report) in a research note issued to ...

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...

Truist initiated coverage of Tronox (TROX) with a Buy rating and $17 price target The firm believes Tronox has one of the “strongest ...

In a report released today, Pete Osterland from Truist Financial initiated coverage with a Buy rating on TRONOX (TROX – Research Report) and a ...

Michael Skordeles, head of U.S. Economics at Truist, speaks Tuesday, Jan. 28, 2025, during the Greater Lehigh Valley Chamber ...

As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...